Search Results 241-250 of 17120 for pharmacogenetics
Mayo Clinic discovery could mean better access to more donor hearts and improved transplant outcomes featured · Graduate students' research pushes discoveries ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Adedinsewo D, Dugan J, Johnson PW, Douglass EJ, Morales-Lara AC, Parkulo MA, Ting HH, Cooper LT, Scott LR, Valverde AM, Padmanabhan D, Peters NS, ...
This research study is being done to help characterize cardiovascular disease and improve diagnostic tests. OBJECTIVES. To understand the pathogenesis, ...
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
About this study. The purpose of this study is to establish the prevalence and severity of specific morbid indicators of disease severity such as specific ...
About this study. The purpose of this study is to create a larger database and bio-repository to examine pharmacogenomics in patients with BD type I and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
View funding sources for the Epigenetic Etiology of Human Disease Lab led by Keith Robertson, Ph.D., at Mayo Clinic's campus in Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!